Search for: "B & F System Inc" Results 1521 - 1540 of 2,103
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 May 2015, 11:59 am by Rebecca Tushnet
 A: 110(2) by the way: very difficult for us in digital education space: mediated instruction activities that use work as integral part of class experience under control of instructor analogous to type of performance that would take place live—really problematic b/c the key learning activities are not the type that would happen live. [read post]
26 Aug 2010, 3:23 am
(f/k/a Insurance Corporation of Hannover) and Clarendon Insurance Group Inc., and their reinsurer, American Constantine Insurance Co., the U.S. [read post]
28 Aug 2014, 6:24 am by Schachtman
Merrell Dow Pharms., Inc., 89 F. 3d 594, 597 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
6 Mar 2022, 5:46 am by Public Employment Law Press
It also represents certain workers employed by the Unified Court System. [read post]
6 Mar 2022, 5:46 am by Public Employment Law Press
It also represents certain workers employed by the Unified Court System. [read post]
13 May 2021, 2:24 pm by Kevin LaCroix
”  Claims under Section 11 or 12 of the ’33 Act for materially misleading offering materials are subject to a one-year limitations period and general anti-fraud claims under Sections 10(b) of the ’34 Act and SEC Rule 10b-5 are subject to a two-year limitations period. [read post]
14 Jan 2016, 3:28 pm by John Chierichella
  To the contrary, FAR 42‑1204(b) expressly excepts stock purchases from the requirement for Government consent. [read post]
14 Jan 2016, 3:24 pm by John Chierichella and Keith Szeliga
  To the contrary, FAR 42‑1204(b) expressly excepts stock purchases from the requirement for Government consent. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
20 Nov 2022, 7:19 am by Kevin LaCroix
In a lawsuit that includes allegations that involve both of these trends, a plaintiff shareholder has filed a securities class action lawsuit against the women’s online apparel company, Torrid Holdings, Inc. [read post]
12 Nov 2017, 11:00 pm by Kevin LaCroix
This ruling will make it more difficult for public companies defending securities fraud class actions to oppose class certification unless certain indirect evidence of inefficiency is also present.[1] Background In June 2014, the New York Attorney General (“NYAG”) filed suit against Barclays under New York’s Martin Act, alleging that Barclays concealed information about the operation of its private “dark pool” trading system, LX. [read post]
15 Jun 2009, 3:00 am
(IPKat) Patent rights ownership confusion - Magna and Russian Sberbank to offer an additional Euro 400 million to be offered in form of no-interest collateral backed loan (IP finance) Global - Copyright Copyright holders acknowledge losing battle for public consciousness at World Copyright Summit (Intellectual Property Watch) Senator Hatch speaks at World Copyright Summit (IP Watchdog) Treaty to improve access to copyrighted materials for visually impaired (IP Osgoode) Africa Nokia named top… [read post]